166 related articles for article (PubMed ID: 9138612)
21. [Therapy in Hodgkin disease and non-Hodgkin lymphomas].
Sréter L
Orv Hetil; 2009 Apr; 150(14):651-5. PubMed ID: 19318337
[TBL] [Abstract][Full Text] [Related]
22. Histopathologic subtypes of indolent lymphomas: caricatures of the mature B-cell system.
Jaffe ES; Raffeld M; Medeiros LJ
Semin Oncol; 1993 Oct; 20(5 Suppl 5):3-30. PubMed ID: 8211205
[No Abstract] [Full Text] [Related]
23. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
24. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
Hansmann ML; Fellbaum C; Hui PK; Lennert K
Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
[TBL] [Abstract][Full Text] [Related]
25. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
26. Malignant lymphomas that mimic benign lymphoid lesions: a review of four lymphomas.
Wilson CS; Chang KL; Weiss LM
Semin Diagn Pathol; 1995 Feb; 12(1):77-86. PubMed ID: 7770676
[TBL] [Abstract][Full Text] [Related]
27. Early Events in Lymphoid Neoplasms and Indolent Follicular Lymphomas.
Perincheri S
Surg Pathol Clin; 2019 Sep; 12(3):719-731. PubMed ID: 31352984
[TBL] [Abstract][Full Text] [Related]
28. [Progress in the treatment of non-Hodgkin's lymphomas].
Varga F; Demeter J
Magy Onkol; 2001; 45(1):45-50. PubMed ID: 12050728
[TBL] [Abstract][Full Text] [Related]
29. Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes.
Corradini P; Ladetto M; Zallio F; Astolfi M; Rizzo E; Sametti S; Cuttica A; Rosato R; Farina L; Boccadoro M; Benedetti F; Pileri A; Tarella C
J Clin Oncol; 2004 Apr; 22(8):1460-8. PubMed ID: 15084619
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Weisenburger DD
Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
[TBL] [Abstract][Full Text] [Related]
31. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
33. Classification of 1,198 cases of bovine lymphoma using the National Cancer Institute Working Formulation for human non-Hodgkin's lymphomas.
Vernau W; Valli VE; Dukes TW; Jacobs RM; Shoukri M; Heeney JL
Vet Pathol; 1992 May; 29(3):183-95. PubMed ID: 1621329
[TBL] [Abstract][Full Text] [Related]
34. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
35. Use of retroviral markers to identify efficacy of purging and origin of relapse following autologous bone marrow and peripheral blood cell transplantation in indolent B cell neoplasms (follicular non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL) patients).
Hum Gene Ther; 1993 Dec; 4(6):821-34. PubMed ID: 8186294
[No Abstract] [Full Text] [Related]
36. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
37. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
[TBL] [Abstract][Full Text] [Related]
38. "Small" B-cell non-Hodgkin's lymphomas with splenomegaly at presentation are either mantle cell lymphoma or marginal zone cell lymphoma. A study based on histology, cytology, immunohistochemistry, and cytogenetic analysis.
Pittaluga S; Verhoef G; Criel A; Wlodarska I; Dierlamm J; Mecucci C; Van den Berghe H; De Wolf-Peeters C
Am J Surg Pathol; 1996 Feb; 20(2):211-23. PubMed ID: 8554111
[TBL] [Abstract][Full Text] [Related]
39. Cytology and immunophenotyping of low- and intermediate-grade B-cell non-Hodgkin's lymphomas with a predominant small-cell component: a study of 56 cases.
Chhieng DC; Cohen JM; Cangiarella JF
Diagn Cytopathol; 2001 Feb; 24(2):90-7. PubMed ID: 11169886
[TBL] [Abstract][Full Text] [Related]
40. Therapy of non-Hodgkin's lymphoma.
Coffey J; Hodgson DC; Gospodarowicz MK
Eur J Nucl Med Mol Imaging; 2003 Jun; 30 Suppl 1():S28-36. PubMed ID: 12692688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
